Crispr Therapeutics shares owned by 180 Wealth Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by 180 Wealth Advisors
from 13F filings
Historical chart of 180 Wealth Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by 180 Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by 180 Wealth Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $205k | 4.4k | 46.98 |
2024-06-30 | $210k | 3.7k | 56.81 |
2022-09-30 | $201k | 3.1k | 65.41 |